Serum arginase, a biomarker of treatment efficacy in human African trypanosomiasis

J Clin Microbiol. 2013 Jul;51(7):2379-81. doi: 10.1128/JCM.03371-12. Epub 2013 Apr 3.

Abstract

Arginase serum levels were increased in human African trypanosomiasis patients and returned to control values after treatment. Arginase hydrolyzes l-arginine to l-ornithine, which is essential for parasite growth. Moreover, l-arginine depletion impairs immune functions. Arginase may be considered as a biomarker for treatment efficacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginase / blood*
  • Biomarkers / blood*
  • Drug Monitoring / methods*
  • Female
  • Humans
  • Male
  • Serum / chemistry
  • Treatment Outcome
  • Trypanosomiasis, African / drug therapy*

Substances

  • Biomarkers
  • Arginase